Global Botulinum Toxin A Supply, Demand and Key Producers, 2024-2030

Global Botulinum Toxin A Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 14 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Botulinum Toxin Type A is a purified neurotoxin derived from the bacterium Clostridium botulinum. It is used medically and cosmetically to temporarily relax muscles by blocking the release of acetylcholine at the neuromuscular junction. This effect is achieved through a process known as neuromuscular blockade, which helps reduce the appearance of wrinkles, treat muscle spasms, and manage certain medical conditions such as chronic migraines and overactive bladder. The treatment is administered through injections and typically results in a temporary reduction of muscle activity, lasting from several months to a year, depending on the individual and the condition being treated.

The global Botulinum Toxin A market size is expected to reach $ 13740 million by 2030, rising at a market growth of 8.0% CAGR during the forecast period (2024-2030).

Growing life expectancy has increased the average age of the population around the world. Because of the growing age of the population, there is increased importance for aesthetics and good looks, which has directly affected the need for Botulinum Toxin Type A treatments positively.

Botulinum Toxin Type A injections help by blocking neurotransmitters that carry pain signals to the brain. Thus, they have been proven significant in decreasing the frequency and duration of migraine in many patients. With increasing cases of stress-triggered migraine and cluster headaches, there has been a significant positive impact on the growth of botulinum toxin injection procedures and Botulinum Toxin Type A treatment.

North America is the largest consumption place, with a revenue market share nearly 67% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 15%.

North America is one of the major contributors to the global market for botulinum toxin. Growing geriatric population presents high demand for Botulinum Toxin Type A procedures. Frequent approvals of various Botulinum Toxin Type A products and rising number of non-surgical procedures in aesthetics are some of the major drivers of the market in the country. Various innovations in the cosmetics industry and improved R&D efforts by key players will present lucrative opportunities over the forecast period in this region.

This report studies the global Botulinum Toxin A demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Botulinum Toxin A, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Botulinum Toxin A that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Botulinum Toxin A total market, 2019-2030, (USD Million)
Global Botulinum Toxin A total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Botulinum Toxin A total market, key domestic companies, and share, (USD Million)
Global Botulinum Toxin A revenue by player, revenue and market share 2019-2024, (USD Million)
Global Botulinum Toxin A total market by Type, CAGR, 2019-2030, (USD Million)
Global Botulinum Toxin A total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Botulinum Toxin A market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, Hugel, Daewoong, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Botulinum Toxin A market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Botulinum Toxin A Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Botulinum Toxin A Market, Segmentation by Type
50IU/Vial
100IU/Vial
Other

Global Botulinum Toxin A Market, Segmentation by Application:
Medical Use
Beauty Use

Companies Profiled:
AbbVie
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
Hugel
Daewoong

Key Questions Answered
1. How big is the global Botulinum Toxin A market?
2. What is the demand of the global Botulinum Toxin A market?
3. What is the year over year growth of the global Botulinum Toxin A market?
4. What is the total value of the global Botulinum Toxin A market?
5. Who are the Major Players in the global Botulinum Toxin A market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Botulinum Toxin A Introduction
1.2 World Botulinum Toxin A Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Botulinum Toxin A Total Market by Region (by Headquarter Location)
1.3.1 World Botulinum Toxin A Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.3 China Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.4 Europe Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.5 Japan Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.6 South Korea Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.7 ASEAN Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.8 India Based Company Botulinum Toxin A Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Botulinum Toxin A Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Botulinum Toxin A Consumption Value (2019-2030)
2.2 World Botulinum Toxin A Consumption Value by Region
2.2.1 World Botulinum Toxin A Consumption Value by Region (2019-2024)
2.2.2 World Botulinum Toxin A Consumption Value Forecast by Region (2025-2030)
2.3 United States Botulinum Toxin A Consumption Value (2019-2030)
2.4 China Botulinum Toxin A Consumption Value (2019-2030)
2.5 Europe Botulinum Toxin A Consumption Value (2019-2030)
2.6 Japan Botulinum Toxin A Consumption Value (2019-2030)
2.7 South Korea Botulinum Toxin A Consumption Value (2019-2030)
2.8 ASEAN Botulinum Toxin A Consumption Value (2019-2030)
2.9 India Botulinum Toxin A Consumption Value (2019-2030)

3 World Botulinum Toxin A Companies Competitive Analysis
3.1 World Botulinum Toxin A Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Botulinum Toxin A Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Botulinum Toxin A in 2023
3.2.3 Global Concentration Ratios (CR8) for Botulinum Toxin A in 2023
3.3 Botulinum Toxin A Company Evaluation Quadrant
3.4 Botulinum Toxin A Market: Overall Company Footprint Analysis
3.4.1 Botulinum Toxin A Market: Region Footprint
3.4.2 Botulinum Toxin A Market: Company Product Type Footprint
3.4.3 Botulinum Toxin A Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Botulinum Toxin A Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Botulinum Toxin A Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Botulinum Toxin A Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Botulinum Toxin A Consumption Value Comparison
4.2.1 United States VS China: Botulinum Toxin A Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Botulinum Toxin A Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Botulinum Toxin A Companies and Market Share, 2019-2024
4.3.1 United States Based Botulinum Toxin A Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Botulinum Toxin A Revenue, (2019-2024)
4.4 China Based Companies Botulinum Toxin A Revenue and Market Share, 2019-2024
4.4.1 China Based Botulinum Toxin A Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Botulinum Toxin A Revenue, (2019-2024)
4.5 Rest of World Based Botulinum Toxin A Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Botulinum Toxin A Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Botulinum Toxin A Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Botulinum Toxin A Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 50IU/Vial
5.2.2 100IU/Vial
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Botulinum Toxin A Market Size by Type (2019-2024)
5.3.2 World Botulinum Toxin A Market Size by Type (2025-2030)
5.3.3 World Botulinum Toxin A Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
6.1 World Botulinum Toxin A Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Medical Use
6.2.2 Beauty Use
6.3 Market Segment by Application
6.3.1 World Botulinum Toxin A Market Size by Application (2019-2024)
6.3.2 World Botulinum Toxin A Market Size by Application (2025-2030)
6.3.3 World Botulinum Toxin A Market Size Market Share by Application (2019-2030)

7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Botulinum Toxin A Product and Services
7.1.4 AbbVie Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Ipsen
7.2.1 Ipsen Details
7.2.2 Ipsen Major Business
7.2.3 Ipsen Botulinum Toxin A Product and Services
7.2.4 Ipsen Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Ipsen Recent Developments/Updates
7.2.6 Ipsen Competitive Strengths & Weaknesses
7.3 Medytox
7.3.1 Medytox Details
7.3.2 Medytox Major Business
7.3.3 Medytox Botulinum Toxin A Product and Services
7.3.4 Medytox Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Medytox Recent Developments/Updates
7.3.6 Medytox Competitive Strengths & Weaknesses
7.4 LIBP
7.4.1 LIBP Details
7.4.2 LIBP Major Business
7.4.3 LIBP Botulinum Toxin A Product and Services
7.4.4 LIBP Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 LIBP Recent Developments/Updates
7.4.6 LIBP Competitive Strengths & Weaknesses
7.5 Merz Pharmaceuticals
7.5.1 Merz Pharmaceuticals Details
7.5.2 Merz Pharmaceuticals Major Business
7.5.3 Merz Pharmaceuticals Botulinum Toxin A Product and Services
7.5.4 Merz Pharmaceuticals Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Merz Pharmaceuticals Recent Developments/Updates
7.5.6 Merz Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Hugel
7.6.1 Hugel Details
7.6.2 Hugel Major Business
7.6.3 Hugel Botulinum Toxin A Product and Services
7.6.4 Hugel Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Hugel Recent Developments/Updates
7.6.6 Hugel Competitive Strengths & Weaknesses
7.7 Daewoong
7.7.1 Daewoong Details
7.7.2 Daewoong Major Business
7.7.3 Daewoong Botulinum Toxin A Product and Services
7.7.4 Daewoong Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Daewoong Recent Developments/Updates
7.7.6 Daewoong Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Botulinum Toxin A Industry Chain
8.2 Botulinum Toxin A Upstream Analysis
8.3 Botulinum Toxin A Midstream Analysis
8.4 Botulinum Toxin A Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Botulinum Toxin A Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Botulinum Toxin A Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Botulinum Toxin A Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Botulinum Toxin A Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Botulinum Toxin A Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Botulinum Toxin A Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Botulinum Toxin A Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Botulinum Toxin A Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Botulinum Toxin A Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Botulinum Toxin A Players in 2023
Table 12. World Botulinum Toxin A Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Botulinum Toxin A Company Evaluation Quadrant
Table 14. Head Office of Key Botulinum Toxin A Players
Table 15. Botulinum Toxin A Market: Company Product Type Footprint
Table 16. Botulinum Toxin A Market: Company Product Application Footprint
Table 17. Botulinum Toxin A Mergers & Acquisitions Activity
Table 18. United States VS China Botulinum Toxin A Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Botulinum Toxin A Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Botulinum Toxin A Companies, Headquarters (States, Country)
Table 21. United States Based Companies Botulinum Toxin A Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Botulinum Toxin A Revenue Market Share (2019-2024)
Table 23. China Based Botulinum Toxin A Companies, Headquarters (Province, Country)
Table 24. China Based Companies Botulinum Toxin A Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Botulinum Toxin A Revenue Market Share (2019-2024)
Table 26. Rest of World Based Botulinum Toxin A Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Botulinum Toxin A Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Botulinum Toxin A Revenue Market Share (2019-2024)
Table 29. World Botulinum Toxin A Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Botulinum Toxin A Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Botulinum Toxin A Market Size by Type (2025-2030) & (USD Million)
Table 32. World Botulinum Toxin A Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Botulinum Toxin A Market Size by Application (2019-2024) & (USD Million)
Table 34. World Botulinum Toxin A Market Size by Application (2025-2030) & (USD Million)
Table 35. AbbVie Basic Information, Manufacturing Base and Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Botulinum Toxin A Product and Services
Table 38. AbbVie Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. AbbVie Recent Developments/Updates
Table 40. AbbVie Competitive Strengths & Weaknesses
Table 41. Ipsen Basic Information, Manufacturing Base and Competitors
Table 42. Ipsen Major Business
Table 43. Ipsen Botulinum Toxin A Product and Services
Table 44. Ipsen Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Ipsen Recent Developments/Updates
Table 46. Ipsen Competitive Strengths & Weaknesses
Table 47. Medytox Basic Information, Manufacturing Base and Competitors
Table 48. Medytox Major Business
Table 49. Medytox Botulinum Toxin A Product and Services
Table 50. Medytox Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Medytox Recent Developments/Updates
Table 52. Medytox Competitive Strengths & Weaknesses
Table 53. LIBP Basic Information, Manufacturing Base and Competitors
Table 54. LIBP Major Business
Table 55. LIBP Botulinum Toxin A Product and Services
Table 56. LIBP Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. LIBP Recent Developments/Updates
Table 58. LIBP Competitive Strengths & Weaknesses
Table 59. Merz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Merz Pharmaceuticals Major Business
Table 61. Merz Pharmaceuticals Botulinum Toxin A Product and Services
Table 62. Merz Pharmaceuticals Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Merz Pharmaceuticals Recent Developments/Updates
Table 64. Merz Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Hugel Basic Information, Manufacturing Base and Competitors
Table 66. Hugel Major Business
Table 67. Hugel Botulinum Toxin A Product and Services
Table 68. Hugel Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Hugel Recent Developments/Updates
Table 70. Hugel Competitive Strengths & Weaknesses
Table 71. Daewoong Basic Information, Manufacturing Base and Competitors
Table 72. Daewoong Major Business
Table 73. Daewoong Botulinum Toxin A Product and Services
Table 74. Daewoong Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Daewoong Recent Developments/Updates
Table 76. Daewoong Competitive Strengths & Weaknesses
Table 77. Global Key Players of Botulinum Toxin A Upstream (Raw Materials)
Table 78. Global Botulinum Toxin A Typical Customers


List of Figures
Figure 1. Botulinum Toxin A Picture
Figure 2. World Botulinum Toxin A Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Botulinum Toxin A Total Revenue (2019-2030) & (USD Million)
Figure 4. World Botulinum Toxin A Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Botulinum Toxin A Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 13. Botulinum Toxin A Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 16. World Botulinum Toxin A Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 18. China Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 23. India Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Botulinum Toxin A by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Botulinum Toxin A Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Botulinum Toxin A Markets in 2023
Figure 27. United States VS China: Botulinum Toxin A Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Botulinum Toxin A Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Botulinum Toxin A Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Botulinum Toxin A Market Size Market Share by Type in 2023
Figure 31. 50IU/Vial
Figure 32. 100IU/Vial
Figure 33. Other
Figure 34. World Botulinum Toxin A Market Size Market Share by Type (2019-2030)
Figure 35. World Botulinum Toxin A Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Botulinum Toxin A Market Size Market Share by Application in 2023
Figure 37. Medical Use
Figure 38. Beauty Use
Figure 39. World Botulinum Toxin A Market Size Market Share by Application (2019-2030)
Figure 40. Botulinum Toxin A Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
Hugel
Daewoong
btl

Related Reports

Global Botulinum Toxin A Market 2023 by Company, Regions, Type and Application, Forecast to 2029 xian22

Global Botulinum Toxin A Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.

Global Botulinum Toxin A Market 2024 by Company, Regions, Type and Application, Forecast to 2030 xian22

Global Botulinum Toxin A Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 14 Sep 2024

date Pharma & Healthcare

Botulinum Toxin Type A is a purified neurotoxin derived from the bacterium Clostridium botulinum. It is used medically and cosmetically to temporarily relax muscles by blocking the release of acetylcholine at the neuromuscular junction. This effect is achieved through a process known as neuromuscular blockade, which helps reduce the appearance of wrinkles, treat muscle spasms, and manage certain medical conditions such as chronic migraines and overactive bladder. The treatment is administered through injections and typically results in a temporary reduction of muscle activity, lasting from several months to a year, depending on the individual and the condition being treated.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Botulinum Toxin A Supply, Demand and Key Producers, 2024-2030

Global Botulinum Toxin A Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 14 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Botulinum Toxin Type A is a purified neurotoxin derived from the bacterium Clostridium botulinum. It is used medically and cosmetically to temporarily relax muscles by blocking the release of acetylcholine at the neuromuscular junction. This effect is achieved through a process known as neuromuscular blockade, which helps reduce the appearance of wrinkles, treat muscle spasms, and manage certain medical conditions such as chronic migraines and overactive bladder. The treatment is administered through injections and typically results in a temporary reduction of muscle activity, lasting from several months to a year, depending on the individual and the condition being treated.

The global Botulinum Toxin A market size is expected to reach $ 13740 million by 2030, rising at a market growth of 8.0% CAGR during the forecast period (2024-2030).

Growing life expectancy has increased the average age of the population around the world. Because of the growing age of the population, there is increased importance for aesthetics and good looks, which has directly affected the need for Botulinum Toxin Type A treatments positively.

Botulinum Toxin Type A injections help by blocking neurotransmitters that carry pain signals to the brain. Thus, they have been proven significant in decreasing the frequency and duration of migraine in many patients. With increasing cases of stress-triggered migraine and cluster headaches, there has been a significant positive impact on the growth of botulinum toxin injection procedures and Botulinum Toxin Type A treatment.

North America is the largest consumption place, with a revenue market share nearly 67% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 15%.

North America is one of the major contributors to the global market for botulinum toxin. Growing geriatric population presents high demand for Botulinum Toxin Type A procedures. Frequent approvals of various Botulinum Toxin Type A products and rising number of non-surgical procedures in aesthetics are some of the major drivers of the market in the country. Various innovations in the cosmetics industry and improved R&D efforts by key players will present lucrative opportunities over the forecast period in this region.

This report studies the global Botulinum Toxin A demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Botulinum Toxin A, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Botulinum Toxin A that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Botulinum Toxin A total market, 2019-2030, (USD Million)
Global Botulinum Toxin A total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Botulinum Toxin A total market, key domestic companies, and share, (USD Million)
Global Botulinum Toxin A revenue by player, revenue and market share 2019-2024, (USD Million)
Global Botulinum Toxin A total market by Type, CAGR, 2019-2030, (USD Million)
Global Botulinum Toxin A total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Botulinum Toxin A market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, Hugel, Daewoong, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Botulinum Toxin A market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Botulinum Toxin A Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Botulinum Toxin A Market, Segmentation by Type
50IU/Vial
100IU/Vial
Other

Global Botulinum Toxin A Market, Segmentation by Application:
Medical Use
Beauty Use

Companies Profiled:
AbbVie
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
Hugel
Daewoong

Key Questions Answered
1. How big is the global Botulinum Toxin A market?
2. What is the demand of the global Botulinum Toxin A market?
3. What is the year over year growth of the global Botulinum Toxin A market?
4. What is the total value of the global Botulinum Toxin A market?
5. Who are the Major Players in the global Botulinum Toxin A market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Botulinum Toxin A Introduction
1.2 World Botulinum Toxin A Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Botulinum Toxin A Total Market by Region (by Headquarter Location)
1.3.1 World Botulinum Toxin A Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.3 China Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.4 Europe Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.5 Japan Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.6 South Korea Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.7 ASEAN Based Company Botulinum Toxin A Revenue (2019-2030)
1.3.8 India Based Company Botulinum Toxin A Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Botulinum Toxin A Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Botulinum Toxin A Consumption Value (2019-2030)
2.2 World Botulinum Toxin A Consumption Value by Region
2.2.1 World Botulinum Toxin A Consumption Value by Region (2019-2024)
2.2.2 World Botulinum Toxin A Consumption Value Forecast by Region (2025-2030)
2.3 United States Botulinum Toxin A Consumption Value (2019-2030)
2.4 China Botulinum Toxin A Consumption Value (2019-2030)
2.5 Europe Botulinum Toxin A Consumption Value (2019-2030)
2.6 Japan Botulinum Toxin A Consumption Value (2019-2030)
2.7 South Korea Botulinum Toxin A Consumption Value (2019-2030)
2.8 ASEAN Botulinum Toxin A Consumption Value (2019-2030)
2.9 India Botulinum Toxin A Consumption Value (2019-2030)

3 World Botulinum Toxin A Companies Competitive Analysis
3.1 World Botulinum Toxin A Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Botulinum Toxin A Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Botulinum Toxin A in 2023
3.2.3 Global Concentration Ratios (CR8) for Botulinum Toxin A in 2023
3.3 Botulinum Toxin A Company Evaluation Quadrant
3.4 Botulinum Toxin A Market: Overall Company Footprint Analysis
3.4.1 Botulinum Toxin A Market: Region Footprint
3.4.2 Botulinum Toxin A Market: Company Product Type Footprint
3.4.3 Botulinum Toxin A Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Botulinum Toxin A Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Botulinum Toxin A Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Botulinum Toxin A Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Botulinum Toxin A Consumption Value Comparison
4.2.1 United States VS China: Botulinum Toxin A Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Botulinum Toxin A Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Botulinum Toxin A Companies and Market Share, 2019-2024
4.3.1 United States Based Botulinum Toxin A Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Botulinum Toxin A Revenue, (2019-2024)
4.4 China Based Companies Botulinum Toxin A Revenue and Market Share, 2019-2024
4.4.1 China Based Botulinum Toxin A Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Botulinum Toxin A Revenue, (2019-2024)
4.5 Rest of World Based Botulinum Toxin A Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Botulinum Toxin A Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Botulinum Toxin A Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Botulinum Toxin A Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 50IU/Vial
5.2.2 100IU/Vial
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Botulinum Toxin A Market Size by Type (2019-2024)
5.3.2 World Botulinum Toxin A Market Size by Type (2025-2030)
5.3.3 World Botulinum Toxin A Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
6.1 World Botulinum Toxin A Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Medical Use
6.2.2 Beauty Use
6.3 Market Segment by Application
6.3.1 World Botulinum Toxin A Market Size by Application (2019-2024)
6.3.2 World Botulinum Toxin A Market Size by Application (2025-2030)
6.3.3 World Botulinum Toxin A Market Size Market Share by Application (2019-2030)

7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Botulinum Toxin A Product and Services
7.1.4 AbbVie Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Ipsen
7.2.1 Ipsen Details
7.2.2 Ipsen Major Business
7.2.3 Ipsen Botulinum Toxin A Product and Services
7.2.4 Ipsen Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Ipsen Recent Developments/Updates
7.2.6 Ipsen Competitive Strengths & Weaknesses
7.3 Medytox
7.3.1 Medytox Details
7.3.2 Medytox Major Business
7.3.3 Medytox Botulinum Toxin A Product and Services
7.3.4 Medytox Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Medytox Recent Developments/Updates
7.3.6 Medytox Competitive Strengths & Weaknesses
7.4 LIBP
7.4.1 LIBP Details
7.4.2 LIBP Major Business
7.4.3 LIBP Botulinum Toxin A Product and Services
7.4.4 LIBP Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 LIBP Recent Developments/Updates
7.4.6 LIBP Competitive Strengths & Weaknesses
7.5 Merz Pharmaceuticals
7.5.1 Merz Pharmaceuticals Details
7.5.2 Merz Pharmaceuticals Major Business
7.5.3 Merz Pharmaceuticals Botulinum Toxin A Product and Services
7.5.4 Merz Pharmaceuticals Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Merz Pharmaceuticals Recent Developments/Updates
7.5.6 Merz Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Hugel
7.6.1 Hugel Details
7.6.2 Hugel Major Business
7.6.3 Hugel Botulinum Toxin A Product and Services
7.6.4 Hugel Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Hugel Recent Developments/Updates
7.6.6 Hugel Competitive Strengths & Weaknesses
7.7 Daewoong
7.7.1 Daewoong Details
7.7.2 Daewoong Major Business
7.7.3 Daewoong Botulinum Toxin A Product and Services
7.7.4 Daewoong Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Daewoong Recent Developments/Updates
7.7.6 Daewoong Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Botulinum Toxin A Industry Chain
8.2 Botulinum Toxin A Upstream Analysis
8.3 Botulinum Toxin A Midstream Analysis
8.4 Botulinum Toxin A Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Botulinum Toxin A Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Botulinum Toxin A Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Botulinum Toxin A Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Botulinum Toxin A Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Botulinum Toxin A Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Botulinum Toxin A Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Botulinum Toxin A Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Botulinum Toxin A Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Botulinum Toxin A Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Botulinum Toxin A Players in 2023
Table 12. World Botulinum Toxin A Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Botulinum Toxin A Company Evaluation Quadrant
Table 14. Head Office of Key Botulinum Toxin A Players
Table 15. Botulinum Toxin A Market: Company Product Type Footprint
Table 16. Botulinum Toxin A Market: Company Product Application Footprint
Table 17. Botulinum Toxin A Mergers & Acquisitions Activity
Table 18. United States VS China Botulinum Toxin A Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Botulinum Toxin A Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Botulinum Toxin A Companies, Headquarters (States, Country)
Table 21. United States Based Companies Botulinum Toxin A Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Botulinum Toxin A Revenue Market Share (2019-2024)
Table 23. China Based Botulinum Toxin A Companies, Headquarters (Province, Country)
Table 24. China Based Companies Botulinum Toxin A Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Botulinum Toxin A Revenue Market Share (2019-2024)
Table 26. Rest of World Based Botulinum Toxin A Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Botulinum Toxin A Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Botulinum Toxin A Revenue Market Share (2019-2024)
Table 29. World Botulinum Toxin A Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Botulinum Toxin A Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Botulinum Toxin A Market Size by Type (2025-2030) & (USD Million)
Table 32. World Botulinum Toxin A Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Botulinum Toxin A Market Size by Application (2019-2024) & (USD Million)
Table 34. World Botulinum Toxin A Market Size by Application (2025-2030) & (USD Million)
Table 35. AbbVie Basic Information, Manufacturing Base and Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Botulinum Toxin A Product and Services
Table 38. AbbVie Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. AbbVie Recent Developments/Updates
Table 40. AbbVie Competitive Strengths & Weaknesses
Table 41. Ipsen Basic Information, Manufacturing Base and Competitors
Table 42. Ipsen Major Business
Table 43. Ipsen Botulinum Toxin A Product and Services
Table 44. Ipsen Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Ipsen Recent Developments/Updates
Table 46. Ipsen Competitive Strengths & Weaknesses
Table 47. Medytox Basic Information, Manufacturing Base and Competitors
Table 48. Medytox Major Business
Table 49. Medytox Botulinum Toxin A Product and Services
Table 50. Medytox Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Medytox Recent Developments/Updates
Table 52. Medytox Competitive Strengths & Weaknesses
Table 53. LIBP Basic Information, Manufacturing Base and Competitors
Table 54. LIBP Major Business
Table 55. LIBP Botulinum Toxin A Product and Services
Table 56. LIBP Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. LIBP Recent Developments/Updates
Table 58. LIBP Competitive Strengths & Weaknesses
Table 59. Merz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Merz Pharmaceuticals Major Business
Table 61. Merz Pharmaceuticals Botulinum Toxin A Product and Services
Table 62. Merz Pharmaceuticals Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Merz Pharmaceuticals Recent Developments/Updates
Table 64. Merz Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Hugel Basic Information, Manufacturing Base and Competitors
Table 66. Hugel Major Business
Table 67. Hugel Botulinum Toxin A Product and Services
Table 68. Hugel Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Hugel Recent Developments/Updates
Table 70. Hugel Competitive Strengths & Weaknesses
Table 71. Daewoong Basic Information, Manufacturing Base and Competitors
Table 72. Daewoong Major Business
Table 73. Daewoong Botulinum Toxin A Product and Services
Table 74. Daewoong Botulinum Toxin A Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Daewoong Recent Developments/Updates
Table 76. Daewoong Competitive Strengths & Weaknesses
Table 77. Global Key Players of Botulinum Toxin A Upstream (Raw Materials)
Table 78. Global Botulinum Toxin A Typical Customers


List of Figures
Figure 1. Botulinum Toxin A Picture
Figure 2. World Botulinum Toxin A Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Botulinum Toxin A Total Revenue (2019-2030) & (USD Million)
Figure 4. World Botulinum Toxin A Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Botulinum Toxin A Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Botulinum Toxin A Revenue (2019-2030) & (USD Million)
Figure 13. Botulinum Toxin A Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 16. World Botulinum Toxin A Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 18. China Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 23. India Botulinum Toxin A Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Botulinum Toxin A by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Botulinum Toxin A Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Botulinum Toxin A Markets in 2023
Figure 27. United States VS China: Botulinum Toxin A Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Botulinum Toxin A Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Botulinum Toxin A Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Botulinum Toxin A Market Size Market Share by Type in 2023
Figure 31. 50IU/Vial
Figure 32. 100IU/Vial
Figure 33. Other
Figure 34. World Botulinum Toxin A Market Size Market Share by Type (2019-2030)
Figure 35. World Botulinum Toxin A Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Botulinum Toxin A Market Size Market Share by Application in 2023
Figure 37. Medical Use
Figure 38. Beauty Use
Figure 39. World Botulinum Toxin A Market Size Market Share by Application (2019-2030)
Figure 40. Botulinum Toxin A Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
Hugel
Daewoong
btl

Related Reports

Global Botulinum Toxin A Market 2023 by Company, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Botulinum Toxin A Market 2023 by Company, Regions, Type and Application, Forecast to 2029

industry 18 Mar 2023

industry Pharma & Healthcare

Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.

Global Botulinum Toxin A Market 2024 by Company, Regions, Type and Application, Forecast to 2030 xian22
q3

Global Botulinum Toxin A Market 2024 by Company, Regions, Type and Application, Forecast to 2030

industry 14 Sep 2024

industry Pharma & Healthcare

Botulinum Toxin Type A is a purified neurotoxin derived from the bacterium Clostridium botulinum. It is used medically and cosmetically to temporarily relax muscles by blocking the release of acetylcholine at the neuromuscular junction. This effect is achieved through a process known as neuromuscular blockade, which helps reduce the appearance of wrinkles, treat muscle spasms, and manage certain medical conditions such as chronic migraines and overactive bladder. The treatment is administered through injections and typically results in a temporary reduction of muscle activity, lasting from several months to a year, depending on the individual and the condition being treated.

jiaGou

Add To Cart

gouMai

Buy Now